Fall 2011 (Vol. 28, No. 3)
A Message from the President
2011 has been an extraordinary year for melanoma treatments, with the introduction of not one but two new life-extending melanoma drugs. In March, as reported in the Spring 2011 issue of Sun & Skin News, the US Food and Drug Administration (FDA) approved YervoyTM (ipilimumab), the first new melanoma drug in 13 years. The availability of any new treatment for melanoma, which will cause an estimated 8,790 deaths in the US this year alone, is exciting. But YervoyTM has garnered particular enthusiasm: it is the first therapy proven to extend overall survival for patients with advanced disease. Many patients treated with YervoyTM may have a two-year survival advantage, and a smaller percentage may be virtually cured.Sun and Skin News: Fall 2011 (Vol. 28, No. 3)
Breakthrough Melanoma Drug Approved
The US Food and Drug Administration (FDA) has approved a new drug – the first of its kind – for the treatment of inoperable or advanced metastatic (spreading) melanoma. Read More
More Evidence that UV Tanning Is Addictive
Exposure to ultraviolet (UV) radiation from tanning machines stimulates the “rewards center” in the brains of frequent UV tanners, which could cause tanning addiction, according to a new study in Addiction Biology.Read More
California Enacts Nation's Strictest Teen Tanning Law
Children under the age of 18 have been banned from indoor ultraviolet (UV) tanning in California.Read More
Ask the Expert
Are sunscreens safe? I have heard that their ingredients can cause cancer.Read More